The MLL partial tandem duplication in acute myeloid leukaemia

British Journal of Haematology

Volumn 135, Issue 4, 2006, Pages 438-449

  Basecke, Jorg ^a   Whelan, Jarrett T ^b   Griesinger, Frank ^a   Bertrand, Fred E ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Acute myeloid leukaemia; Leukaemogenesis; MLL; Tandem duplication

Indexed keywords

GENE PRODUCT; PROTEIN MLL PTD; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; CHROMOSOME 11Q; CLINICAL OBSERVATION; GENE DUPLICATION; GENE FUSION; HUMAN; KARYOTYPE; LEUKEMOGENESIS; MLL GENE; ONCOGENE; PARTIAL TANDEM DUPLICATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURVIVAL; TRISOMY 11;

ACUTE DISEASE; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 11; DNA, NEOPLASM; GENE DUPLICATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKEMIA, MYELOID; MYELOID-LYMPHOID LEUKEMIA PROTEIN; PROGNOSIS; TANDEM REPEAT SEQUENCES; TRISOMY;

EID: 33750087521     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06301.x     Document Type: Review

References (81)

1. Abramovich, C. & Humphries, R.K. (2005) Hox regulation of normal and leukemic hematopoietic stem cells. Current Opinion of Hematology, 12, 210-216.
2. Andersson, A., Eden, P., Lindgren, D., Nilsson, J., Lassen, C., Heldrup, J., Fontes, M., Borg, A., Mitelman, F., Johansson, B., Hoglund, M. & Fioretos, T. (2005a) Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations. Leukemia, 19, 1042-1050.
3. Andersson, A., Olofsson, T., Lindgren, D., Nilsson, B., Ritz, C., Eden, P., Lassen, C., Rade, J., Fontes, M., Morse, H., Heldrup, J., Behrendtz, M., Mitelman, F., Hoglund, M., Johansson, B. & Fioretos, T. (2005b) Molecular signatures in childhood acute leukemia and their correlations to expression patterns in normal hematopoietic subpopulations. Proceedings of the National Academy of Sciences of the United States of America, 102, 19069-19074.
4. Armstrong, S.A., Staunton, J.E., Silverman, L.B., Pieters, R., den Boer, M.L., Minden, M.D., Sallan, S.E., Lander, E.S., Golub, T.R. & Korsmeyer, S.J. (2002) MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nature Genetics, 30, 41-47.
5. Ayton, P.M. & Cleary, M.L. (2001) Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene, 20, 5695-5707.
6. Ayton, P.M. & Cleary, M.L. (2003) Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes and Development, 17, 2298-2307.
7. Bacher, U., Kern, W., Schnittger, S., Hiddemann, W., Haferlach, T. & Schoch, C. (2005) Population-based age-specific incidences of cytogenetic subgroups of acute myeloid leukemia. Haematologica, 90, 1502-1510.
8. Basecke, J., Cepek, L., Mannhalter, C., Krauter, J., Hildenhagen, S., Brittinger, G., Trumper, L. & Griesinger, F. (2002a) Transcription of AML1/ETO in bone marrow and cord blood of individuals without acute myelogenous leukemia. Blood, 100, 2267-2268.
9. Basecke, J., Griesinger, F., Trumper, L. & Brittinger, G. (2002b) Leukemia-and lymphoma-associated genetic aberrations in healthy individuals. Annals of Hematology, 81, 64-75.
10. Basecke, J., Podleschny, M., Clemens, R., Schnittger, S., Viereck, V., Trumper, L. & Griesinger, F. (2006) Lifelong persistence of AML associated MLL partial tandem duplications (MLL-PTD) in healthy adults. Leukemia Research, 9, 1091-1096
11. Bertrand, F.E., Vogtenhuber, C., Shah, N. & LeBien, T.W. (2001) Pro-B-cell to pre-B-cell development in B-lineage acute lymphoblastic leukemia expressing the MLL/AF4 fusion protein. Blood, 98, 3398-3405.
12. Bertrand, F.E., Spengeman, J.D., Shah, N. & LeBien, T.W. (2003) B-cell development in the presence of the MLL/AF4 oncoprotein proceeds in the absence of HOX A7 and HOX A9 expression. Leukemia, 17, 2454-2459.
13. Caligiuri, M.A., Schichman, S.A., Strout, M.P., Mrozek, K., Baer, M.R., Frankel, S.R., Barcos, M., Herzig, G.P., Croce, C.M. & Bloomfield, C.D. (1994) Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations. Cancer Research, 54, 370-373.
14. Caligiuri, M.A., Strout, M.P., Lawrence, D., Arthur, D.C., Baer, M.R., Yu, F., Knuutila, S., Mrozek, K., Oberkircher, A.R., Marcucci, G., de la Chapelle, A., Elonen, E., Block, A.W., Rao, P.N., Herzig, G.P., Powell, B.L., Ruutu, T., Schiffer, C.A. & Bloomfield, C.D. (1998) Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. Cancer Research, 58, 55-59.
15. Christiansen, D.H. & Pedersen-Bjergaard, J. (2001) Internal tandem duplications of the FLT3 and MLL genes are mainly observed in atypical cases of therapy-related acute myeloid leukemia with a normal karyotype and are unrelated to type of previous therapy. Leukemia, 15, 1848-1851.
16. Daser, A. & Rabbitts, T.H. (2004) Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis. Genes and Development, 18, 965-974.
17. Daser, A. & Rabbitts, T.H. (2005) The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis. Seminars in Cancer Biology, 15, 175-188.
18. De Pitta, C., Tombolan, L., Campo, D.M., Accordi, B., Te, K.G., Romualdi, C., Vitulo, N., Basso, G. & Lanfranchi, G. (2005) A leukemia-enriched cDNA microarray platform identifies new transcripts with relevance to the biology of pediatric acute lymphoblastic leukemia. Haematologica, 90, 890-898.
19. Dik, W.A., Brahim, W., Braun, C., Asnafi, V., Dastugue, N., Bernard, O.A., van Dongen, J.J., Langerak, A.W., Macintyre, E.A. & Delabesse, E. (2005) CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes. Leukemia, 19, 1948-1957.
20. DiMartino, J.F. & Cleary, M.L. (1999) Mll rearrangements in haematological malignancies: lessons from clinical and biological studies. British Journal of Haematology, 106, 614-626.
21. Djabali, M., Selleri, L., Parry, P., Bower, M., Young, B.D. & Evans, G.A. (1992) A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias. Nature Genetics, 2, 113-118.
22. Dobson, C.L., Warren, A.J., Pannell, R., Forster, A. & Rabbitts, T.H. (2000) Tumorigenesis in mice with a fusion of the leukaemia oncogene Mll and the bacterial lacZ gene. EMBO Journal, 19, 843-851.
23. Dohner, K., Tobis, K., Ulrich, R., Frohling, S., Benner, A., Schlenk, R.F. & Dohner, H. (2002) Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm. Journal of Clinical Oncology, 20, 3254-3261.
24. Eguchi, M., Eguchi-Ishimae, M. & Greaves, M. (2004) The small oligomerization domain of gephyrin converts MLL to an oncogene. Blood, 103, 3876-3882.
25. Ernst, P., Fisher, J.K., Avery, W., Wade, S., Foy, D. & Korsmeyer, S.J. (2004) Definitive hematopoiesis requires the mixed-lineage leukemia gene. Developmental Cell, 6, 437-443.
26. Goto, H., Shimazaki, C., Tatsumi, T., Yamagata, N., Inaba, T., Fujita, N., Moriguchi, T., Yamamoto, K., Seto, M. & Ueda, R. (1994) Acute myelomonocytic leukemia after treatment with chronic oral etoposide: are MLL and LTG9 genes targets for etoposide? International Journal of Hematology, 60, 145-149.
27. Grier, D.G., Thompson, A., Kwasniewska, A., McGonigle, G.J., Halliday, H.L. & Lappin, T.R. (2005) The pathophysiology of HOX genes and their role in cancer. Journal of Pathology, 205, 154-171.
28. Gu, Y., Nakamura, T., Alder, H., Prasad, R., Canaani, O., Cimino, G., Croce, C.M. & Canaani, E. (1992) The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell, 71, 701-708.
29. Guenther, M.G., Jenner, R.G., Chevalier, B., Nakamura, T., Croce, C.M., Canaani, E. & Young, R.A. (2005) Global and Hox-specific roles for the MLL1 methyltransferase. Proceedings of the National Academy of Sciences of the United States of America, 102, 8603-8608.
30. Haferlach, T., Schnittger, S., Kern, W., Hiddemann, W. & Schoch, C. (2004) Genetic classification of acute myeloid leukemia (AML). Annals of Hematology, 83 (Suppl. 1): S97-S100.
31. Hess, J.L. (2004) Mechanisms of transformation by MLL. Critical Reviews in Eukaryotic Gene Expression, 14, 235-254.
32. Hess, J.L., Yu, B.D., Li, B., Hanson, R. & Korsmeyer, S.J. (1997) Defects in yolk sac hematopoiesis in Mll-null embryos. Blood, 90, 1799-1806.
33. Hsu, K. & Look, A.T. (2003) Turning on a dimer: new insights into MLL chimeras. Cancer Cell, 4, 81-83.
34. Jamal, R., Taketani, T., Taki, T., Bessho, F., Hongo, T., Hamaguchi, H., Horiike, S., Taniwaki, M., Hanada, R., Nakamura, H. & Hayashi, Y. (2001) Coduplication of the MLL and FLT3 genes in patients with acute myeloid leukemia. Genes, Chromosomes and Cancer, 31, 187-190.
35. Kohlmann, A., Schoch, C., Schnittger, S., Dugas, M., Hiddemann, W., Kern, W. & Haferlach, T. (2004) Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients. Leukemia, 18, 63-71.
36. Kohlmann, A., Schoch, C., Dugas, M., Schnittger, S., Hiddemann, W., Kern, W. & Haferlach, T. (2005) New insights into MLL gene rearranged acute leukemias using gene expression profiling: shared pathways, lineage commitment, and partner genes. Leukemia, 19, 953-964.
37. Kuchinskaya, E., Heyman, M., Grander, D., Linderholm, M., Soderhall, S., Zaritskey, A., Nordgren, A., Porwit-MacDonald, A., Zueva, E., Pawitan, Y., Corcoran, M., Nordenskjold, M. & Blennow, E. (2005) Children and adults with acute lymphoblastic leukaemia have similar gene expression profiles. European Journal of Haematology, 74, 466-480.
38. Kumar, A.R., Hudson, W.A., Chen, W., Nishiuchi, R., Yao, Q. & Kersey, J.H. (2004) Hoxa9 influences the phenotype but not the incidence of Mll-AF9 fusion gene leukemia. Blood, 103, 1823-1828.
39. Libura, M., Asnafi, V., Tu, A., Delabesse, E., Tigaud, I., Cymbalista, F., Bennaceur-Griscelli, A., Villarese, P., Solbu, G., Hagemeijer, A., Beldjord, K., Hermine, O. & Macintyre, E. (2003) FLT3 and MLL intragenic abnormalities in AML reflect a common category of genotoxic stress. Blood, 102, 2198-2204.
40. Marcucci, G., Strout, M.P., Bloomfield, C.D. & Caligiuri, M.A. (1998) Detection of unique ALL1 (MLL) fusion transcripts in normal human bone marrow and blood: distinct origin of normal versus leukemic ALL1 fusion transcripts. Cancer Research, 58, 790-793.
41. Maroc, N., Morel, A., Beillard, E., De La Chapelle, A.L., Fund, X., Mozziconacci, M.J., Dupont, M., Cayuela, J.M., Gabert, J., Koki, A., Fert, V. & Hermitte, F. (2004) A diagnostic biochip for the comprehensive analysis of MLL translocations in acute leukemia. Leukemia, 18, 1522-1530.
42. Martin, M.E., Milne, T.A., Bloyer, S., Galoian, K., Shen, W., Gibbs, D., Brock, H.W., Slany, R. & Hess, J.L. (2003) Dimerization of MLL fusion proteins immortalizes hematopoietic cells. Cancer Cell, 4, 197-207.
43. Meyer, C., Schneider, B., Jakob, S., Strehl, S., Attarbaschi, A., Schnittger, S., Schoch, C., Jansen, M.W., van Dongen, J.J., den Boer, M.L., Pieters, R., Ennas, M.G., Angelucci, E., Koehl, U., Greil, J., Griesinger, F., Zur, S.U., Eckert, C., Szczepanski, T., Niggli, F.K., Schafer, B.W., Kempski, H., Brady, H.J., Zuna, J., Trka, J., Nigro, L.L., Biondi, A., Delabesse, E., Macintyre, E., Stanulla, M., Schrappe, M., Haas, O.A., Burmeister, T., Dingermann, T., Klingebiel, T. & Marschalek, R. (2006) The MLL recombinome of acute leukemias. Leukemia, 20, 777-784.
44. Milne, T.A., Briggs, S.D., Brock, H.W., Martin, M.E., Gibbs, D., Allis, C.D. & Hess, J.L. (2002) MLL targets SET domain methyltransferase activity to Hox gene promoters. Molecular Cell, 10, 1107-1117.
45. Milne, T.A., Martin, M.E., Brock, H.W., Slany, R.K. & Hess, J.L. (2005a) Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications. Cancer Research, 65, 11367-11374.
46. Milne, T.A., Hughes, C.M., Lloyd, R., Yang, Z., Rozenblatt-Rosen, O., Dou, Y., Schnepp, R.W., Krankel, C., Livolsi, V.A., Gibbs, D., Hua, X., Roeder, R.G., Meyerson, M. & Hess, J.L. (2005b) Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proceedings of the National Academy of Sciences of the United States of America, 102, 749-754.
47. Munoz, L., Nomdedeu, J.F., Villamor, N., Guardia, R., Colomer, D., Ribera, J.M., Torres, J.P., Berlanga, J.J., Fernandez, C., Llorente, A., Queipo de Llano, M.P., Sanchez, J.M., Brunet, S. & Sierra, J. (2003) Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells. Leukemia, 17, 76-82.
48. Nasr, F., Macintyre, E., Venuat, A.M., Bayle, C., Carde, P. & Ribrag, V. (1997) Translocation t(4;11)(q21;q23) and MLL gene rearrangement in acute lymphoblastic leukemia secondary to anti topoisomerase II anticancer agents. Leukemia and Lymphoma, 25, 399-401.
49. Nilson, I., Lochner, K., Siegler, G., Greil, J., Beck, J.D., Fey, G.H. & Marschalek, R. (1996) Exon/intron structure of the human ALL-1 (MLL) gene involved in translocations to chromosomal region 11q23 and acute leukaemias. British Journal of Haematology, 93, 966-972.
50. Okada, Y., Feng, Q., Lin, Y., Jiang, Q., Li, Y., Coffield, V.M., Su, L., Xu, G. & Zhang, Y. (2005) hDOT1L links histone methylation to leukemogenesis. Cell, 121, 167-178.
51. Olesen, L.H., Nyvold, C.G., Aggerholm, A., Norgaard, J.M., Guldberg, P. & Hokland, P. (2005a) Delineation and molecular characterization of acute myeloid leukemia patients with coduplication of FLT3 and MLL. European Journal of Haematology, 75, 185-192.
52. Olesen, L.H., Aggerholm, A., Andersen, B.L., Nyvold, C.G., Guldberg, P., Norgaard, J.M. & Hokland, P. (2005b) Molecular typing of adult acute myeloid leukaemia: significance of translocations, tandem duplications, methylation, and selective gene expression profiling. British Journal of Haematology, 131, 457-467.
53. Ozeki, K., Kiyoi, H., Hirose, Y., Iwai, M., Ninomiya, M., Kodera, Y., Miyawaki, S., Kuriyama, K., Shimazaki, C., Akiyama, H., Nishimura, M., Motoji, T., Shinagawa, K., Takeshita, A., Ueda, R., Ohno, R., Emi, N. & Naoe, T. (2004) Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia. Blood, 103, 1901-1908.
54. Pallisgaard, N., Hokland, P., Riishoj, D.C., Pedersen, B. & Jorgensen, P. (1998) Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood, 92, 574-588.
55. Pentao, L., Wise, C.A., Chinault, A.C., Patel, P.I. & Lupski, J.R. (1992) Charcot-Marie-Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit. Nature Genetics, 2, 292-300.
56. Rege-Cambrin, G., Giugliano, E., Michaux, L., Stul, M., Scaravaglio, P., Serra, A., Saglio, G. & Hagemeijer, A. (2005) Trisomy 11 in myeloid malignancies is associated with internal tandem duplication of both MLL and FLT3 genes. Haematologica, 90, 262-264.
57. Ross, M.E., Zhou, X., Song, G., Shurtleff, S.A., Girtman, K., Williams, W.K., Liu, H.C., Mahfouz, R., Raimondi, S.C., Lenny, N., Patel, A. & Downing, J.R. (2003) Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood, 102, 2951-2959.
58. Ross, M.E., Mahfouz, R., Onciu, M., Liu, H.C., Zhou, X., Song, G., Shurtleff, S.A., Pounds, S., Cheng, C., Ma, J., Ribeiro, R.C., Rubnitz, J.E., Girtman, K., Williams, W.K., Raimondi, S.C., Liang, D.C., Shih, L.Y., Pui, C.H. & Downing, J.R. (2004) Gene expression profiling of pediatric acute myelogenous leukemia. Blood, 104, 3679-3687.
59. Schichman, S.A., Caligiuri, M.A., Gu, Y., Strout, M.P., Canaani, E., Bloomfield, C.D. & Croce, C.M. (1994a) ALL-1 partial duplication in acute leukemia. Proceedings of the National Academy of Sciences of the United States of America, 91, 6236-6239.
60. Schichman, S.A., Caligiuri, M.A., Strout, M.P., Carter, S.L., Gu, Y., Canaani, E., Bloomfield, C.D. & Croce, C.M. (1994b) ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements. Cancer Research, 54, 4277-4280.
61. Schnittger, S., Wormann, B., Hiddemann, W. & Griesinger, F. (1998) Partial tandem duplications of the MLL gene are detectable in peripheral blood and bone marrow of nearly all healthy donors. Blood, 92, 1728-1734.
62. Schnittger, S., Kinkelin, U., Schoch, C., Heinecke, A., Haase, D., Haferlach, T., Buchner, T., Wormann, B., Hiddemann, W. & Griesinger, F. (2000) Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML. Leukemia, 14, 796-804.
63. Shiah, H.S., Kuo, Y.Y., Tang, J.L., Huang, S.Y., Yao, M., Tsay, W., Chen, Y.C., Wang, C.H., Shen, M.C., Lin, D.T., Lin, K.H. & Tien, H.F. (2002) Clinical and biological implications of partial tandem duplication of the MLL gene in acute myeloid leukemia without chromosomal abnormalities at 11q23. Leukemia, 16, 196-202.
64. Shih, L.Y., Liang, D.C., Fu, J.F., Wu, J.H., Wang, P.N., Lin, T.L., Dunn, P., Kuo, M.C., Tang, T.C., Lin, T.H. & Lai, C.L. (2005) Characterization of fusion partner genes in 114 patients with de novo acute myeloid leukemia and MLL rearrangement. Leukemia, 20, 218-223.
65. So, C.W. & Cleary, M.L. (2003) Common mechanism for oncogenic activation of MLL by forkhead family proteins. Blood, 101, 633-639.
66. So, C.W. & Cleary, M.L. (2004) Dimerization: a versatile switch for oncogenesis. Blood, 104, 919-922.
67. So, C.W., Lin, M., Ayton, P.M., Chen, E.H. & Cleary, M.L. (2003) Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias. Cancer Cell, 4, 99-110.
68. So, C.W., Karsunky, H., Wong, P., Weissman, I.L. & Cleary, M.L. (2004) Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9. Blood, 103, 3192-3199.
69. Steudel, C., Wermke, M., Schaich, M., Schakel, U., Illmer, T., Ehninger, G. & Thiede, C. (2003) Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia. Genes, Chromosomes and Cancer, 37, 237-251.
70. Strehl, S., Borkhardt, A., Slany, R., Fuchs, U.E., Konig, M. & Haas, O.A. (2003) The human LASP1 gene is fused to MLL in an acute myeloid leukemia with t(11;17)(q23;q21). Oncogene, 22, 157-160.
71. Strout, M.P., Marcucci, G., Bloomfield, C.D. & Caligiuri, M.A. (1998) The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-mediated homologous recombination in acute myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America, 95, 2390-2395.
72. Tkachuk, D.C., Kohler, S. & Cleary, M.L. (1992) Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell, 71, 691-700.
73. Weisser, M., Kern, W., Schoch, C., Hiddemann, W., Haferlach, T. & Schnittger, S. (2005) Risk assessment by monitoring expression levels of partial tandem duplications in the MLL gene in acute myeloid leukemia during therapy. Haematologica, 90, 881-889.
74. Whitman, S.P., Liu, S., Vukosavljevic, T., Rush, L.J., Yu, L., Liu, C., Klisovic, M.I., Maharry, K., Guimond, M., Strout, M.P., Becknell, B., Dorrance, A., Klisovic, R.B., Plass, C., Bloomfield, C.D., Marcucci, G. & Caligiuri, M.A. (2005) The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy. Blood, 106, 345-352.
75. Xia, Z.B., Popovic, R., Chen, J., Theisler, C., Stuart, T., Santillan, D.A., Erfurth, F., Diaz, M.O. & Zeleznik, L. (2005) The MLL fusion gene, MLL-AF4, regulates cyclin-dependent kinase inhibitor CDKN1B (p27kip1) expression. Proceedings of the National Academy of Sciences of the United States of America, 102, 14028-14033.
76. Yagi, H., Deguchi, K., Aono, A., Tani, Y., Kishimoto, T. & Komori, T. (1998) Growth disturbance in fetal liver hematopoiesis of Mll-mutant mice. Blood, 92, 108-117.
77. Yeoh, E.J., Ross, M.E., Shurtleff, S.A., Williams, W.K., Patel, D., Mahfouz, R., Behm, F.G., Raimondi, S.C., Relling, M.V., Patel, A., Cheng, C., Campana, D., Wilkins, D., Zhou, X., Li, J., Liu, H., Pui, C.H., Evans, W.E., Naeve, C., Wong, L. & Downing, J.R. (2002) Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell, 1, 133-143.
78. Yu, B.D., Hess, J.L., Horning, S.E., Brown, G.A. & Korsmeyer, S.J. (1995) Altered Hox expression and segmental identity in Mll-mutant mice. Nature, 378, 505-508.
79. Yu, M., Honoki, K., Andersen, J., Paietta, E., Nam, D.K. & Yunis, J.J. (1996) MLL tandem duplication and multiple splicing in adult acute myeloid leukemia with normal karyotype. Leukemia, 10, 774-780.
80. Yu, B.D., Hanson, R.D., Hess, J.L., Horning, S.E. & Korsmeyer, S.J. (1998) MLL, a mammalian trithorax-group gene, functions as a transcriptional maintenance factor in morphogenesis. Proceedings of the National Academy of Sciences of the United States of America, 95, 10632-10636.
81. Ziemin-van der Poel, S., McCabe, N.R., Gill, H.J., Espinosa, R., III, Patel, Y., Harden, A., Rubinelli, P., Smith, S.D., LeBeau, M.M. & Rowley, J.D. (1991) Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proceedings of the National Academy of Sciences of the United States of America, 88, 10735-10739.